Wird geladen...
Clinicians’ guide to the use of fecal calprotectin to identify and monitor disease activity in inflammatory bowel disease
BACKGROUND: Objective monitoring of the severity of inflammation in patients with inflammatory bowel disease (IBD) is an essential part of disease management. However, repeat endoscopy to define extent and severity of inflammation is not practical. Fecal calprotectin (FC) is a biomarker that can be...
Gespeichert in:
| Veröffentlicht in: | Can J Gastroenterol Hepatol |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Pulsus Group Inc
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4610647/ https://ncbi.nlm.nih.gov/pubmed/26125109 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|